The Tufts Center for the Study of Drug development (CSDD) is funded in part by unrestricted grants from pharmaceutical and biotechnology firms

  Having  a fox guard the chicken coop 

The Tufts Center for the Study of Drug development (CSDD) is funded in part by unrestricted grants from pharmaceutical and biotechnology firms, as well as companies that provide related services (e.g., contract research, consulting, and technology firms) to the research-based industry. Tufts CSDD's financial disclosure statement can be found here: http://csdd.tufts.edu/about/financial_disclosure. The authors and Tufts CSDD did not receive any external funding to conduct this study. The R&D cost and expenditure data for individual compounds and companies are proprietary and cannot be redistributed. Other data used were obtained from subscription databases and the Food and Drug Administration (FDA) and other websites


U try to look at the  financial disclosure website  and  this is  what i get 

We couldn't find the page you were looking for. This is either because:

• There is an error in the URL entered into your web browser. Please check the URL and try again.
• The page you are looking for has been moved or deleted.

You can return to our homepage by clicking here, or you can try searching for the content you are seeking by clicking here.

The Tufts Center for the Study of Drug development (CSDD) study is widely sited for  talking about the   costs of bringing a new medication to the market